- Our governance framework
- Background systems (including IT) and analysis models
- Alternative reimbursement pricing models
- Legal and statutory compliance understanding and monitoring processes
- Quality policies, procedures and standards
- Formulary procurement processes
- A nursing dashboard in southern Africa
- United States (US) Food and Drug Administration (FDA) approved niche isotope
For more information, refer to our corporate governance overview
| ✓ |
- New business lines and service offerings developed
|
| ✓ |
- Ability to drive efficiencies throughout the business
|
| ✓ |
- Clinical governance, quality and safety board sub-committee ensures quality standards are maintained and improved
|
| ✓ |
- IT utilised to drive standardisation, reduction in administrative costs and economies of scale
|
| ✓ |
- Knowledge sharing of best practice collaboration among territories
|
Actions to enhance our outcome
- Embedding our newly developed digital strategy throughout the business
- Focus on governance maturity
- Driving compliance with established processes and systems at the point of care
| ✓ |
Positive |
|
 |
Negative |